PaxMedica
PXMD
#8672
Rank
$1.64 M
Marketcap
$0.21
Share price
0.00%
Change (1 day)
-75.06%
Change (1 year)

P/E ratio for PaxMedica (PXMD)

P/E ratio as of July 2024 (TTM): -0.0086

According to PaxMedica's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.00863192. At the end of 2022 the company had a P/E ratio of -0.1841.

P/E ratio history for PaxMedica from 2022 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-0.1841

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.